# Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer

> **NCT01593293** · PHASE3 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 266 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** PemCarbo
- **DRUG:** Pem only

## Key facts

- **NCT ID:** NCT01593293
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-03
- **Primary completion:** 2014-11
- **Final completion:** 2015-11
- **Target enrollment:** 266 (ESTIMATED)
- **Last updated:** 2012-05-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01593293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01593293, "Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01593293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
